Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-24

Clinical Trial Update: Fructose Malabsorption in Northern Norway [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial conducted in Northern Norway investigated fructose malabsorption with irritable bowel syndrome; the study sponsored by Universi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital of North Norway | Conditions: Irritable Bowel Syndrome, Fructose Malabsorption | Phase 2, Phase 3 | Status: COMPLETED